The global artificial insemination market size is expected to reach USD 4.01 billion by 2030 registering a CAGR of 8.6% from 2024 to 2030. Over the past few years, infertility has become a major public health concern across the globe. Artificial insemination is usually the preferred first-line treatment to tackle infertility. Lifestyle changes, delay in pregnancy, and hormonal issues are some of the reasons contributing to the rise in fertility-related problems. According to the United Nations, the global fertility rate is expected to decline to 2.2% by 2050. In developing or underdeveloped nations, medical consultation regarding infertility was not easily accessible.
Hence, there was a lack of awareness about available assisted reproductive techniques including artificial or donor insemination and IVF. The average cost of performing an IUI is around USD 865. The success rate for each cycle is around 4 to 5%, which can be increased to about 7 to 16% by consuming fertility drugs. However, older women are not encouraged to go through IUI due to slim chances of success and further complications. Several fertility problems can be addressed through IUI, such as semen allergy, unexplained infertility, and Sexually Transmitted Diseases (STDs).
This product will be delivered within 1-3 business days.
Hence, there was a lack of awareness about available assisted reproductive techniques including artificial or donor insemination and IVF. The average cost of performing an IUI is around USD 865. The success rate for each cycle is around 4 to 5%, which can be increased to about 7 to 16% by consuming fertility drugs. However, older women are not encouraged to go through IUI due to slim chances of success and further complications. Several fertility problems can be addressed through IUI, such as semen allergy, unexplained infertility, and Sexually Transmitted Diseases (STDs).
Artificial Insemination Market Report Highlights
- Intrauterine insemination (IUI) dominated the market with 71.7% of revenue share in 2023. This is due to its relatively simple procedure, minimal invasiveness, and effectiveness in treating various infertility issues.
- AIH-Husband dominated the market with 66.8% of revenue share in 2023. This is due to the increasing awareness and acceptance of assisted reproductive technologies among couples facing infertility challenges.
- Fertility clinics & others dominated the market with 53.2% share in 2023. These clinics offer a controlled environment with experienced medical professionals to perform the procedure, maximizing its effectiveness.
- Asia Pacific artificial insemination market dominated the market with 30.1% share in 2023. This growth is attributed to the rising number of infertile couples and technological advancements in the fertility segment.
The leading players in the Artificial Insemination market include:
- Vitrolife
- Genea Pty Limited
- Rinovum Women’s Health, LLC
- Pride Angel
- HI-TECH SOLUTIONS
- FUJIFILM Irvine Scientific
- Kitazato Corporation
- Rocket Medical plc
- Conceivex, Inc.
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players worldwide.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
- COVID-19's impact and how to sustain in these fast-evolving markets
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Artificial Insemination Market Variables, Trends, & Scope
Chapter 4. Artificial Insemination Market: Type Estimates & Trend Analysis
Chapter 5. Artificial Insemination Market: Source Estimates & Trend Analysis
Chapter 6. Artificial Insemination Market: End Use Estimates & Trend Analysis
Chapter 7. Artificial Insemination Market: Regional Estimates & Trend Analysis
Chapter 8. Competitive Landscape
Companies Mentioned
The leading players in the Artificial Insemination market include:- Vitrolife
- Genea Pty Limited
- Rinovum Women’s Health, LLC
- Pride Angel
- HI-TECH SOLUTIONS
- FUJIFILM Irvine Scientific
- Kitazato Corporation
- Rocket Medical plc
- Conceivex, Inc.
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 80 |
| Published | September 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 2.26 Billion |
| Forecasted Market Value ( USD | $ 4.01 Billion |
| Compound Annual Growth Rate | 8.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
